WallStreetZenWallStreetZen

NASDAQ: BWAY
Brainsway Ltd Stock Forecast, Predictions & Price Target

Analyst price target for BWAY

Based on 2 analysts offering 12 month price targets for Brainsway Ltd.
Min Forecast
$6.00-8.26%
Avg Forecast
$9.00+37.61%
Max Forecast
$12.00+83.49%

Should I buy or sell BWAY stock?

Based on 2 analysts offering ratings for Brainsway Ltd.
Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BWAY stock forecasts and price targets.

BWAY stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-16
lockedlocked$00.00+00.00%2023-09-22

1 of 1

Forecast return on equity

Is BWAY forecast to generate an efficient return?
Company
25.66%
Industry
20.6%
Market
39.25%
BWAY's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BWAY forecast to generate an efficient return on assets?
Company
17.7%
Industry
10.69%
BWAY is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BWAY revenue forecast

What is BWAY's revenue in the next 2 years based on estimates from 3 analysts?
Avg 1 year Forecast
$31.0M+7.56%
Avg 2 year Forecast
$35.1M+22.04%
BWAY's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BWAY revenue growth forecast

How is BWAY forecast to perform vs Medical Devices companies and vs the US market?
Company
10.47%
Industry
5.63%
Market
6.53%
BWAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BWAY's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BWAY vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
BWAY$6.54$9.00+37.61%Buy
MGRM$3.72N/AN/A
PXDT$7.80N/AN/A
TLSI$3.62N/AN/A
HYPR$1.33$2.38+78.57%Buy

Brainsway Stock Forecast FAQ

Is Brainsway Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: BWAY) stock is to Buy BWAY stock.

Out of 2 analysts, 0 (0%) are recommending BWAY as a Strong Buy, 2 (100%) are recommending BWAY as a Buy, 0 (0%) are recommending BWAY as a Hold, 0 (0%) are recommending BWAY as a Sell, and 0 (0%) are recommending BWAY as a Strong Sell.

If you're new to stock investing, here's how to buy Brainsway stock.

What is BWAY's revenue growth forecast for 2023-2024?

(NASDAQ: BWAY) Brainsway's forecast annual revenue growth rate of 10.47% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 5.63%, and it is also forecast to beat the US market's average forecast revenue growth rate of 6.53%.

Brainsway's revenue in 2023 is $28,789,000.On average, 3 Wall Street analysts forecast BWAY's revenue for 2023 to be $1,023,529,200, with the lowest BWAY revenue forecast at $1,021,347,681, and the highest BWAY revenue forecast at $1,024,653,013.

In 2024, BWAY is forecast to generate $1,161,262,397 in revenue, with the lowest revenue forecast at $1,133,728,979 and the highest revenue forecast at $1,189,919,628.

What is BWAY's forecast return on assets (ROA) for 2023-2025?

(NASDAQ: BWAY) forecast ROA is 17.7%, which is higher than the forecast US Medical Devices industry average of 10.69%.

What is BWAY's Price Target?

According to 2 Wall Street analysts that have issued a 1 year BWAY price target, the average BWAY price target is $9.00, with the highest BWAY stock price forecast at $12.00 and the lowest BWAY stock price forecast at $6.00.

On average, Wall Street analysts predict that Brainsway's share price could reach $9.00 by Nov 16, 2024. The average Brainsway stock price prediction forecasts a potential upside of 37.61% from the current BWAY share price of $6.54.

What is BWAY's forecast return on equity (ROE) for 2023-2025?

(NASDAQ: BWAY) forecast ROE is 25.66%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.